-
Electronic (PDF)
-
Site License
-
Enterprisewide
The Future of the In-Vitro Diagnostics Market to 2016 - Increasing Diagnostic Procedures Drive Demand
GBI Research, January 2010, Pages: 142
“The Future of the In-Vitro Diagnostics Market to 2016 - Increasing Diagnostic Procedures Drive Demand” provides key data, information and analysis on the global in-vitro diagnostics market, a key segment within the medical equipment industry. This medical device report provides market landscape, competitive landscape and market trends information on seven in-vitro diagnostics market categories - Clinical Chemistry, Genetic Testing, Histology and Cytology, Immuno Chemistry, Infectious Immunology, Microbiology Culture and Haematology. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.
Scope
- Key geographies including the US (United States), Canada, the UK (United Kingdom), Germany, France, Italy, Spain, Belgium, Netherlands, Japan, China, India, Australia, Taiwan, republic of Korea, Brazil, Argentina, Mexico, Israel and South Africa.
- Global Market size and company share data for seven In-Vitro Diagnostics market categories – clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture and haematology.
- Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2008.
- Qualitative analysis of key market trends, market drivers and restraints by categories and segments.
- Competitive landscape and key company profiles. Key players covered include Roche, Siemens Healthcare, Abbott, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, Becton, Dickinson (BD), Bio-Rad Laboratories, Inverness Medical Innovations, Sysmex, Gen-Probe and Dade Behring.
- Key in-pipeline products and technologies expected to hit the global In-Vitro Diagnostics market in the near future.
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the In-Vitro Diagnostics market globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline. Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What’s the next big thing in the In-Vitro Diagnostics market landscape? – Identify, understand and capitalize
- Make more informed business decisions from the insightful and in-depth analysis of the In-Vitro Diagnostics market and the factors shaping it.
1.1 List of Tables
1.2 List of Figures
2 Introduction and Overview
2.1 In-Vitro-Diagnostics (IVD) Overview
3 Global In-Vitro Diagnostics (IVD) Market: Market Characterization
3.1 Global In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009
3.2 Global In-Vitro Diagnostics (IVD) Market, Revenue Forecasts ($m), 2009 – 2016
3.3 Global In-Vitro Diagnostics (IVD) Market, Company Share (%), 2008
3.4 Global In-Vitro Diagnostics (IVD) Market, Key Market Trends
3.4.1 Entry of Diagnostic Imaging Players into the In-Vitro Diagnostics (IVD) Market Has Set Stage for New Technologies to Be Developed By Marrying the Two Disciplines
3.4.2 Large Number of Private Equity/ Venture Capital (PE/VC) Investments and Collaborations in the In-Vitro Diagnostics (IVD) Sector to Fuel Innovation
3.4.3 Consolidation of Laboratories across the World
3.5 Global In-Vitro Diagnostics (IVD) Market: Key Technology Trends
3.5.1 Emerging Technologies for Cutting Lab Costs
3.5.2 New Technologies Improve Speed and Accuracy
3.6 Global In-Vitro Diagnostics (IVD) Market, Market Drivers
3.6.1 Economic Market Drivers
3.6.2 Technological Market Drivers
3.6.3 Regulatory Market Drivers
3.6.4 Social Market Drivers
3.7 In-Vitro Diagnostics (IVD) Market, Market Restraints
3.7.1 Economic Market Restraints
3.7.2 Social Market Restraints
4 Global In-Vitro Diagnostics (IVD) Market: Category Analysis and Forecasts
4.1 Clinical Chemistry Market: Market Characterization
4.1.1 Global Clinical Chemistry Market, Revenue ($m), 2002–2009
4.1.2 Global Clinical Chemistry Market, Revenue Forecasts ($m), 2009–2016
4.1.3 Global Clinical Chemistry Market, Company Share (%), 2008
4.1.4 Clinical Chemistry Market: Market Drivers
4.1.5 Clinical Chemistry Market: Market Restraints
4.2 Immuno Chemistry Market: Market Characterization
4.2.1 Global Immuno Chemistry Market, Revenue ($m), 2002 – 2009
4.2.2 Global Immuno Chemistry Market, Revenue Forecast ($m), 2009 – 2016
4.2.3 Global Immuno Chemistry Market, Company Share (%), 2008
4.2.4 Immuno Chemistry Market: Market Drivers
4.2.5 Immuno Chemistry Market: Market Restraints
4.3 Haematology Market: Market Characterization
4.3.1 Global Haematology Market, Revenues ($m), 2002 – 2009
4.3.2 Global Haematology Market, Revenue Forecasts ($m), 2009 – 2016
4.3.3 Global Haematology Market, Company Share (%), 2008
4.3.4 Haematology Market: Market Drivers
4.3.5 Haematology Market: Market Restraints
4.4 Histology and Cytology Market: Market Characterization
4.4.1 Global Histology and Cytology Market, Revenue ($m), 2002 – 2009
4.4.2 Global Histology and Cytology Market, Revenue Forecasts ($m), 2009 – 2016
4.4.3 Global Histology and Cytology Market, Company Share (%), 2008
4.4.4 Histology and Cytology Market: Market Drivers
4.4.5 Histology and Cytology Market: Market Restraints
4.5 Microbiology Culture Market: Market Characterization
4.5.1 Global Microbiology Culture Market, Revenue ($m), 2002 – 2009
4.5.2 Global Microbiology Culture Market, Revenue Forecasts ($m), 2009 – 2016
4.5.3 Global Microbiology Culture Market, Company Share (%), 2008
4.5.4 Global Microbiology Culture Market: Market Drivers
4.5.5 Microbiology Culture Market: Market Restraints
4.6 Infectious Immunology Market: Market Characterization
4.6.1 Global Infectious Immunology Market, Revenue ($m), 2002 – 2009
4.6.2 Global Infectious Immunology Market, Revenue Forecasts ($m), 2009 – 2016
4.6.3 Global Infectious Immunology Market, Company Share (%), 2008
4.6.4 Global Infectious Immunology Market: Market Drivers
4.6.5 Global Infectious Immunology Market: Market Restraints
4.7 Genetic Testing Market: Market Characterization
4.7.1 Global Genetic Testing Market, Revenue ($m), 2002 – 2009
4.7.2 Global Genetic Testing Market, Revenue Forecasts ($m), 2009 – 2016
4.7.3 Global Genetic Testing Market, Company Share (%), 2008
4.7.4 Global Genetic Testing Market: Market Drivers
4.7.5 Global Genetic Testing Market: Market Restraints
5 Global In-Vitro Diagnostics (IVD) Market: Country Analysis and Forecasts
5.1 Global In-Vitro Diagnostics (IVD)Market: Geographic Trends Analysis
5.2 Market Characterization, North America, 2002 – 2016
5.2.1 The US In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009
5.2.2 The US In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016
5.2.3 Canada In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009
5.2.4 North America In-Vitro Diagnostics (IVD) Market, Market Drivers
5.2.5 North America In-Vitro Diagnostics (IVD) Market, Market Restraints
5.3 Market Characterization, Europe, 2002 – 2016
5.3.1 The UK In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009
5.3.2 The UK In-Vitro Diagnostics (IVD) Market, Revenues ($m), 2009 – 2016
5.3.3 Germany In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009
5.3.4 Germany In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016
5.3.5 France In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009
5.3.6 France In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016
5.3.7 Italy In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009
5.3.8 Italy In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016
5.3.9 Spain In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009
5.3.10 Spain In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016
5.3.11 Belgium In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009
5.3.12 Belgium In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016
5.3.13 The Netherlands In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009
5.3.14 The Netherlands In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016
5.3.15 Europe In-Vitro Diagnostics (IVD) Market, Market Drivers
5.3.16 Europe In-Vitro Diagnostics (IVD) Market, Market Restraints
5.4 Market Characterization, Asia Pacific, 2002 – 2016
5.4.1 Japan In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009
5.4.2 Japan In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016
5.4.3 China In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009
5.4.4 China In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016
5.4.5 India In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009
5.4.6 India In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016
5.4.7 Australia In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009
5.4.8 Australia In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016
5.4.9 Taiwan In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009
5.4.10 Taiwan In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016
5.4.11 Republic of Korea In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009
5.4.12 Republic of Korea In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016
5.4.13 Asia Pacific In-Vitro Diagnostics (IVD) Market, Market Drivers
5.4.14 Asia Pacific In-Vitro Diagnostics (IVD) Market, Market Restraints
5.5 Market Characterization, South and Central America, 2002 – 2016
5.5.1 Brazil In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009
5.5.2 Brazil In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016
5.5.3 Argentina In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009
5.5.4 Argentina In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016
5.5.5 Mexico In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009
5.5.6 Mexico In-Vitro Diagnostics (IVD) Market, Revenues ($m), 2009 – 2016
5.5.7 South and Central America In-Vitro Diagnostics (IVD) Market, Market Drivers
5.5.8 South and Central America In-Vitro Diagnostics (IVD) Market, Market Restraints
5.6 Market Characterization, Middle East and Africa, 2002 – 2016
5.6.1 Israel In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009
5.6.2 Israel In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016
5.6.3 South Africa In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009
5.6.4 South Africa In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016
5.6.5 Middle East and Africa In-Vitro Diagnostics (IVD) Market, Market Drivers
5.6.6 Middle East and Africa In-Vitro Diagnostics (IVD) Market, Market Restraints
6 Global In-Vitro Diagnostics (IVD) Market: Strategic Competitive Assessment
6.1 Key Market Participants
6.1.1 F. Hoffmann-La Roche Ltd
6.1.2 Siemens Medical Solutions
6.1.3 Abbott Laboratories
6.1.4 Beckman Coulter, Inc
6.1.5 bioMerieux Sa
6.1.6 Ortho-Clinical Diagnostics
6.1.7 Becton, Dickinson and Company
6.1.8 Bio-Rad Laboratories, Inc
6.1.9 Inverness Medical Innovations, Inc
7 Global In-Vitro Diagnostics (IVD) Market: Product Pipeline Analysis
7.1 Pipeline Products Analysis by Category
7.1.1 Pipeline Products Analysis: Immuno Chemistry Market
7.1.2 Pipeline Products Analysis: Infectious Immunology
7.2 Key Pipeline Products Currently Undergoing Development
7.2.1 Clinical Chemistry Pipeline Products
7.2.2 Genetic Testing
7.2.3 Haematology
7.2.4 Immunochemistry
7.2.5 Infectious Immunology
7.2.6 Microbiology Culture
7.2.7 Histology and Cytology
8 Global In-Vitro Diagnostics (IVD) Market: Consolidation Landscape
8.1 Deals by Type, 2006 – 2009
8.2 Deals by Value and Volume, 2006 – 2009
8.3 List of Deals in 2009
8.4 Top 10 Acquisitions By Value, 2009
8.4.1 Agilent Technologies Receives Shareholders Approval To Acquire Varian
8.4.2 Beckman Coulter Completes Acquisition Of Olympus-DS From OLYMPUS
8.4.3 MDS Receives Shareholder Approval To Sell MDS Analytical Technologies To Danaher
8.4.4 Thermo Fisher Scientific Completes Acquisition Of B.R.A.H.M.S
8.4.5 Corning Acquires Axygen BioScience And Its Subsidiaries From American Capital
8.4.6 Becton, Dickinson and Company Completes Acquisition Of HandyLab
8.4.7 Inverness Medical Innovations Completes Acquisition Of Concateno From Marwyn
8.4.8 Laboratory Corporation of America Holdings Completes Acquisition Of Monogram Biosciences
8.4.9 Gen-Probe Acquires Tepnel Life Sciences
9 Appendix
9.1 Definitions
9.1.1 Clinical Chemistry
9.1.2 Immunochemistry Test Reagents
9.1.3 Haematology
9.1.4 Histology And Cytology
9.1.5 Microbiology Culture
9.1.6 Infectious Immunology
9.1.7 Genetic Testing
9.2 Acronyms
9.3 Methodology
9.3.1 Secondary Research
9.3.2 Primary Research
9.3.3 Models
9.3.4 Forecasts
9.3.5 Expert Panels
9.4 Contact Us
9.5 Disclaimer
List of Tables:
Table 1: In-Vitro Diagnostics (IVD) Market, Global, Revenue ($m), 2002-2009
Table 2: In-Vitro Diagnostics (IVD) Market, Global, Revenue ($m), 2009-2016
Table 3: In-Vitro Diagnostics (IVD) Market, Global, Company Share ($m), 2008
Table 4: Clinical Chemistry Market, Global, Revenue ($m), 2002–2009
Table 5: Clinical Chemistry Market, Global, Revenue ($m), 2009–2016
Table 6: Clinical Chemistry Market, Global, Company Share ($m), 2008
Table 7: Immuno Chemistry Market, Global, Revenue ($m), 2002–2009
Table 8: Immuno Chemistry Market, Global, Revenue ($m), 2009–2016
Table 9: Immuno Chemistry Market, Global, Company Share ($m), 2008
Table 10: Haematology Market, Global, Revenues ($m), 2002–2009
Table 11: Haematology Market, Global, Revenue ($m), 2009–2016
Table 12: Haematology Market, Global, Company Share ($m), 2008
Table 13: Histology and Cytology Market, Global, Revenue ($m), 2002–2009
Table 14: Histology and Cytology Market, Global, Revenue ($m), 2009–2016
Table 15: Histology and Cytology Market, Global, Company Share ($m), 2008
Table 16: Microbiology Culture Market, Global, Revenue ($m), 2002–2009
Table 17: Microbiology Culture Market, Global, Revenue ($m), 2009–2016
Table 18: Microbiology Culture Market, Global, Company Share ($m), 2008
Table 19: Infectious Immunology Market, Global, Revenue ($m), 2002–2009
Table 20: Infectious Immunology Market, Global, Revenue ($m), 2009–2016
Table 21: Infectious Immunology Market, Global, Company Share ($m), 2008
Table 22: Genetic Testing Market, Global, Revenue ($m), 2002–2009
Table 23: Genetic Testing Market, Global, Revenue ($m), 2009–2016
Table 24: Global Genetic Testing Market, Global, Company Share ($m), 2008
Table 25: In-Vitro Diagnostics (IVD) Market, US, Revenue ($m), 2002-2009
Table 26: In-Vitro Diagnostics (IVD) Market, US, Revenue ($m), 2009-2016
Table 27: In-Vitro Diagnostics (IVD) Market, Canada, Revenue ($m), 2002-2009
Table 28: In-Vitro Diagnostics (IVD) Market, Canada, Revenue ($m), 2009-2016
Table 29: In-Vitro Diagnostics (IVD) Market, UK, Revenue ($m), 2002-2009
Table 30: In-Vitro Diagnostics (IVD) Market, UK, Revenue ($m), 2009-2016
Table 31: In-Vitro Diagnostics (IVD) Market, Germany, Revenue ($m), 2002-2009
Table 32: In-Vitro Diagnostics (IVD) Market, Germany, Revenue ($m), 2009-2016
Table 33: In-Vitro Diagnostics (IVD) Market, France, Revenue ($m), 2002-2009
Table 34: In-Vitro Diagnostics (IVD) Market, France, Revenue ($m), 2009-2016
Table 35: In-Vitro Diagnostics (IVD) Market, Italy, Revenue ($m), 2002-2009
Table 36: In-Vitro Diagnostics (IVD) Market, Italy, Revenue ($m), 2009-2016
Table 37: In-Vitro Diagnostics (IVD) Market, Spain, Revenue ($m), 2002-2009
Table 38: In-Vitro Diagnostics (IVD) Market, Spain, Revenue ($m), 2009-2016
Table 39: In-Vitro Diagnostics (IVD) Market, Belgium, Revenue ($m), 2002-2009
Table 40: In-Vitro Diagnostics (IVD) Market, Belgium, Revenue ($m), 2009-2016
Table 41: In-Vitro Diagnostics (IVD) Market, The Netherlands, Revenue ($m), 2002-2009
Table 42: In-Vitro Diagnostics (IVD) Market, The Netherlands, Revenue ($m), 2009-2016
Table 43: In-Vitro Diagnostics (IVD) Market, Japan, Revenue ($m), 2002-2009
Table 44: In-Vitro Diagnostics (IVD) Market, Japan, Revenue ($m), 2009-2016
Table 45: In-Vitro Diagnostics (IVD) Market, China, Revenue ($m), 2002-2009
Table 46: In-Vitro Diagnostics (IVD) Market, China, Revenue ($m), 2009-2016
Table 47: In-Vitro Diagnostics (IVD) Market, India, Revenue ($m), 2002-2009
Table 48: In-Vitro Diagnostics (IVD) Market, India, Revenue ($m), 2002-2009
Table 49: In-Vitro Diagnostics (IVD) Market, Australia, Revenue ($m), 2002-2009
Table 50: In-Vitro Diagnostics (IVD) Market, Australia, Revenue ($m), 2009-2016
Table 51: In-Vitro Diagnostics (IVD) Market, Taiwan, Revenue ($m), 2002-2009
Table 52: In-Vitro Diagnostics (IVD) Market, Taiwan, Revenue ($m), 2009-2016
Table 53: In-Vitro Diagnostics (IVD) Market, Republic of Korea, Revenue ($m), 2002-2009
Table 54: In-Vitro Diagnostics (IVD) Market, Republic of Korea, Revenue ($m), 2009-2016
Table 55: In-Vitro Diagnostics (IVD) Market, Brazil, Revenue ($m), 2002-2009
Table 56: In-Vitro Diagnostics (IVD) Market, Brazil, Revenue ($m), 2009-2016
Table 57: In-Vitro Diagnostics (IVD) Market, Argentina, Revenue ($m), 2002-2009
Table 58: In-Vitro Diagnostics (IVD) Market, Argentina, Revenue ($m), 2009-2016
Table 59: In-Vitro Diagnostics (IVD) Market, Mexico, Revenue ($m), 2002-2009
Table 60: In-Vitro Diagnostics (IVD) Market, Mexico, Revenue ($m), 2009-2016
Table 61: In-Vitro Diagnostics (IVD) Market, Israel, Revenue ($m), 2002-2009
Table 62: In-Vitro Diagnostics (IVD) Market, Israel, Revenue ($m), 2009-2016
Table 63: In-Vitro Diagnostics (IVD) Market, South Africa, Revenue ($m), 2002-2009
Table 64: In-Vitro Diagnostics (IVD) Market, South Africa, Revenue ($m), 2009-2016
Table 65: Roche’s Merger and Acquisitions, In-Vitro Diagnostics (IVD) Market, 2007–2009
Table 66: Roche In-Vitro Diagnostics (IVD) Pipeline Product Portfolio
Table 67: Siemens Medical Solutions In-Vitro Diagnostics (IVD) Pipeline Product Portfolio
Table 68: Siemen’s Merger and Acquisitions, In-Vitro Diagnostics (IVD) Market, 2007–2009
Table 69: Abbott Laboratories’ Mergers and Acquisitions, In-Vitro Diagnostics (IVD) Market, 2007–2009
Table 70: Abbott Laboratories In-Vitro Diagnostics (IVD) Pipeline Product Portfolio
Table 71: Beckman Coulter’s Mergers and Acquisitions, In-Vitro Diagnostics (IVD) Market,
2007–2009
Table 72: Beckman Coulter, Inc. In-Vitro Diagnostics (IVD) Pipeline Products
Table 73: bioMerieux’s Mergers and Acquisitions, In-Vitro Diagnostics (IVD) Market, 2007–2009
Table 74: bioMerieux Sa, In-Vitro Diagnostics (IVD) Pipeline Product Portfolio
Table 75: Ortho-Clinical Diagnostics, In-Vitro Diagnostics (IVD) Pipeline Product Portfolio
Table 76: Becton Dickinson, Mergers and Acquisitions, In-Vitro Diagnostics (IVD) Market,
2007–2009
Table 77: Becton, Dickinson Inc. In-Vitro Diagnostics (IVD) Pipeline Product Portfolio
Table 78: Bio-Rad, Merger and Acquisitions, In-Vitro Diagnostics (IVD) Market, 2007–2009
Table 79: Inverness Medical Innovations, Inc., Mergers and Acquisitions, In-Vitro Diagnostics (IVD) Market, 2007–2009
Table 80: Inverness Medical Innovations In-Vitro Diagnostics (IVD) Pipeline Product Portfolio
Table 81: In-Vitro Diagnostics (IVD) Market, Global, Pipeline Products by Category, 2009
Table 82: Immuno Chemistry Market, Global, Pipeline Products Analysis, 2009
Table 83: Infectious Immunology Market, Global, 2009
Table 84: Deals By Type, Global In-Vitro Diagnostics (IVD) Market, 2006-2009
Table 85: Key Deals, Global In-Vitro Diagnostics (IVD) Market, 2009
List of Figures:
Figure 1: In-Vitro Diagnostics (IVD) Market, Global, Revenue ($m), 2002-2009
Figure 2: In-Vitro Diagnostics (IVD) Market, Global, Revenue ($m), 2009-2016
Figure 3: In-Vitro Diagnostics (IVD) Market, Global, Company Share (%), 2008
Figure 4: Global In-Vitro Diagnostics (IVD) Market: Key Market Trends
Figure 5: Global Laboratory Consolidation Landscape, 2005–2009
Figure 6: Global In Vitro Diagnostics Market: Key Technology Trends
Figure 7: Global In-Vitro Diagnostics (IVD) Market: Drivers and Restraints
Figure 8: List of Retail Clinics in the US and Diagnostic In-Vitro Diagnostics (IVD) Tests Offered
Figure 9: Clinical Chemistry Market, Global, Revenue ($m), 2002–2009
Figure 10: Clinical Chemistry Market, Global, Revenue ($m), 2009–2016
Figure 11: Clinical Chemistry Market, Global, Company Share (%), 2008
Figure 12: Immuno Chemistry Market, Global, Revenue ($m), 2002–2009
Figure 13: Immuno Chemistry Market, Global, Revenue ($m), 2009–2016
Figure 14: Immuno Chemistry Market, Global, Company Share (%),2008
Figure 15: Haematology Market, Global, Revenue ($m), 2002–2009
Figure 16: Haematology Market, Global, Revenue ($m), 2009–2016
Figure 17: Haematology Market, Global, Company Share (%), 2008
Figure 18: Histology and Cytology Market, Global, Revenue ($m), 2002–2009
Figure 19: Histology and Cytology Market, Global, Revenue ($m), 2009–2016
Figure 20: Histology and Cytology Market, Global, Company Share (%), 2008
Figure 21: Microbiology Culture Market, Global, Revenue ($m), 2002–2009
Figure 22: Microbiology Culture Market, Global, Revenue ($m), 2009–2016
Figure 23: Microbiology Market, Global, Company Share (%),2008
Figure 24: Infectious Immunology Market, Global, Revenue ($m), 2002–2009
Figure 25: Infectious Immunology Market, Global, Revenue ($m), 2009–2016
Figure 26: Infectious Immunology Market, Global, Company Share (%), 2008
Figure 27: Genetic Testing Market, Global, Revenue ($m), 2002–2009
Figure 28: Genetic Testing Market, Global, Revenue ($m), 2009–2016
Figure 29: Global Genetic Testing Market, Global, Company Share (%),2008
Figure 30: In-Vitro Diagnostics (IVD) Market, Global, Geographic Trends Analysis
Figure 31: In-Vitro Diagnostics (IVD) Market, US, Revenue ($m), 2002-2009
Figure 32: In-Vitro Diagnostics (IVD) Market, US, Revenue ($m), 2009-2016
Figure 33: In-Vitro Diagnostics (IVD) Market, Canada, Revenue ($m), 2002-2009
Figure 34: In-Vitro Diagnostics (IVD) Market, Canada, Revenue ($m), 2009-2016
Figure 35: In-Vitro Diagnostics (IVD) Market, UK, Revenue ($m), 2002-2009
Figure 36: In-Vitro Diagnostics (IVD) Market, UK, Revenue ($m), 2009-2016
Figure 37: In-Vitro Diagnostics (IVD) Market, Germany, Revenue ($m), 2002-2009
Figure 38: In-Vitro Diagnostics (IVD) Market, Germany, Revenue ($m), 2009-2016
Figure 39: In-Vitro Diagnostics (IVD) Market, France, Revenue ($m), 2002-2009
Figure 40: In-Vitro Diagnostics (IVD) Market, France, Revenue ($m), 2009-2016
Figure 41: In-Vitro Diagnostics (IVD) Market, Italy, Revenue ($m), 2002-2009
Figure 42: In-Vitro Diagnostics (IVD) Market, Italy, Revenue ($m), 2009-2016
Figure 43: In-Vitro Diagnostics (IVD) Market, Spain, Revenue ($m), 2002-2009
Figure 44: In-Vitro Diagnostics (IVD) Market, Spain, Revenue ($m), 2009-2016
Figure 45: In-Vitro Diagnostics (IVD) Market, Belgium, Revenue ($m), 2002-2009
Figure 46: In-Vitro Diagnostics (IVD) Market, Belgium, Revenue ($m), 2009-2016
Figure 47: In-Vitro Diagnostics (IVD) Market, The Netherlands, Revenue ($m), 2002-2009
Figure 48: In-Vitro Diagnostics (IVD) Market, The Netherlands, Revenue ($m), 2009-2016
Figure 49: In-Vitro Diagnostics (IVD) Market, Japan, Revenue ($m), 2002-2009
Figure 50: In-Vitro Diagnostics (IVD) Market, Japan, Revenue ($m), 2009-2016
Figure 51: In-Vitro Diagnostics (IVD) Market, China, Revenue ($m), 2002-2009
Figure 52: In-Vitro Diagnostics (IVD) Market, China, Revenue ($m), 2009-2016
Figure 53: In-Vitro Diagnostics (IVD) Market, India, Revenue ($m), 2002-2009
Figure 54: In-Vitro Diagnostics (IVD) Market, India, Revenue ($m), 2002-2009
Figure 55: In-Vitro Diagnostics (IVD) Market, Australia, Revenue ($m), 2002-2009
Figure 56: In-Vitro Diagnostics (IVD) Market, Australia, Revenue ($m), 2009-2016
Figure 57: In-Vitro Diagnostics (IVD) Market, Taiwan, Revenue ($m), 2002-2009
Figure 58: In-Vitro Diagnostics (IVD) Market, Taiwan, Revenue ($m), 2009-2016
Figure 59: In-Vitro Diagnostics (IVD) Market, Republic of Korea, Revenue ($m), 2002-2009
Figure 60: In-Vitro Diagnostics (IVD) Market, Republic of Korea, Revenue ($m), 2009-2016
Figure 61: In-Vitro Diagnostics (IVD) Market, Brazil, Revenue ($m), 2002-2009
Figure 62: In-Vitro Diagnostics (IVD) Market, Brazil, Revenue ($m), 2009-2016
Figure 63: In-Vitro Diagnostics (IVD) Market, Argentina, Revenue ($m), 2002-2009
Figure 64: In-Vitro Diagnostics (IVD) Market, Argentina, Revenue ($m), 2009-2016
Figure 65: In-Vitro Diagnostics (IVD) Market, Mexico, Revenue ($m), 2002-2009
Figure 66: In-Vitro Diagnostics (IVD) Market, Mexico, Revenue ($m), 2009-2016
Figure 67: In-Vitro Diagnostics (IVD) Market, Israel, Revenue ($m), 2002-2009
Figure 68: In-Vitro Diagnostics (IVD) Market, Israel, Revenue ($m), 2009-2016
Figure 69: In-Vitro Diagnostics (IVD) Market, South Africa, Revenue ($m), 2002-2009
Figure 70: In-Vitro Diagnostics (IVD) Market, South Africa, Revenue ($m), 2009-2016
Figure 71: In-Vitro Diagnostics (IVD) Market, Global, Pipeline Products Analysis by Category, 2009
Figure 72: Immuno Chemistry Market, Global, Pipeline Products Analysis, 2009
Figure 73: Infectious Immunology Market, Global, 2009
Figure 74: Deals By Type, Global In-Vitro Diagnostics (IVD) Market, 2006-2009
Figure 75: Deals By Value and Volume, Global In-Vitro Diagnostics (IVD) Market, Value ($m), 2006-2009
Figure 76: GBI Research Methodology
-F. Hoffmann-La Roche Ltd
-Siemens Medical Solutions
-Abbott Laboratories
-Beckman Coulter, Inc.
-bioMerieux Sa
-Ortho-Clinical Diagnostics
-Becton, Dickinson and Company
-Bio-Rad Laboratories, Inc.
-Inverness Medical Innovations, Inc
Product Samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
